Technicals are suggesting a switch is in the wind.
.081 cents is a very strong platform.
Investors are now looking at the massive market this company will be a trail blazer in, with the first FDA approved product of for animals in the cannabinoid market.
Impressive when you consider all the deadwood management from the company has been disposed off along with the excessive spend from sloppy management.
